Search research articles
Contact Us
Filters
Showing results (521-530 of 541) with videos related to
Page
of 55
Sort By:
Plos One
|
July 11, 2022
Development of an aerosol intervention for COVID-19 disease: Tolerability of soluble ACE2 (APN01) administered via nebulizer
Robert H Shoemaker, Reynold A Panettieri, Steven K Libutti, et al.
Nature Communications
|
December 15, 2025
Single cell proteomic analysis defines discrete neutrophil functional states in human glioblastoma
Pranvera Sadiku, Alejandro J Brenes, Rupert L Mayer, et al.
The Journal of Clinical Investigation
|
August 15, 2017
Prolyl hydroxylase 2 inactivation enhances glycogen storage and promotes excessive neutrophilic responses
Pranvera Sadiku, Joseph A Willson, Rebecca S Dickinson, et al.
American Journal of Respiratory and Critical Care Medicine
|
February 1, 2023
NRF2 Activation Reprograms Defects in Oxidative Metabolism to Restore Macrophage Function in Chronic Obstructive Pulmonary Disease
Eilise M Ryan, Pranvera Sadiku, Patricia Coelho, et al.
Neurology
|
January 10, 2002
Epidemiologic study of 203 sibling pairs with Parkinson's disease: the GenePD study
N E Maher, L I Golbe, A M Lazzarini, et al.
The European Respiratory Journal
|
July 30, 2016
High attenuation areas on chest computed tomography in community-dwelling adults: the MESA study
Anna J Podolanczuk, Elizabeth C Oelsner, R Graham Barr, et al.
Wellcome Open Research
|
May 28, 2021
-------A type I IFN, prothrombotic hyperinflammatory neutrophil signature is distinct for COVID-19 ARDS--
Leila Reyes, Manuel A Sanchez-Garcia, Tyler Morrison, et al.
Neurology
|
December 10, 2003
A haplotype at the PARK3 locus influences onset age for Parkinson's disease: the GenePD study
S Karamohamed, A L DeStefano, J B Wilk, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
June 21, 2005
Absence of previously reported variants in the SCNA (G88C and G209A), NR4A2 (T291D and T245G) and the DJ-1 (T497C) genes in familial Parkinson's disease from the GenePD study
Samer Karamohamed, L I Golbe, M H Mark, et al.
Iscience
|
February 28, 2022
Coagulation factor V is a T-cell inhibitor expressed by leukocytes in COVID-19
Jun Wang, Prasanti Kotagiri, Paul A Lyons, et al.
Page
of 55
Search research articles
Search
Showing results (521-530 of 541) with videos related to
Sort By:
Page
of 55
Plos One
|
July 11, 2022
Development of an aerosol intervention for COVID-19 disease: Tolerability of soluble ACE2 (APN01) administered via nebulizer
Robert H Shoemaker, Reynold A Panettieri, Steven K Libutti, et al.
Nature Communications
|
December 15, 2025
Single cell proteomic analysis defines discrete neutrophil functional states in human glioblastoma
Pranvera Sadiku, Alejandro J Brenes, Rupert L Mayer, et al.
The Journal of Clinical Investigation
|
August 15, 2017
Prolyl hydroxylase 2 inactivation enhances glycogen storage and promotes excessive neutrophilic responses
Pranvera Sadiku, Joseph A Willson, Rebecca S Dickinson, et al.
American Journal of Respiratory and Critical Care Medicine
|
February 1, 2023
NRF2 Activation Reprograms Defects in Oxidative Metabolism to Restore Macrophage Function in Chronic Obstructive Pulmonary Disease
Eilise M Ryan, Pranvera Sadiku, Patricia Coelho, et al.
Neurology
|
January 10, 2002
Epidemiologic study of 203 sibling pairs with Parkinson's disease: the GenePD study
N E Maher, L I Golbe, A M Lazzarini, et al.
The European Respiratory Journal
|
July 30, 2016
High attenuation areas on chest computed tomography in community-dwelling adults: the MESA study
Anna J Podolanczuk, Elizabeth C Oelsner, R Graham Barr, et al.
Wellcome Open Research
|
May 28, 2021
-------A type I IFN, prothrombotic hyperinflammatory neutrophil signature is distinct for COVID-19 ARDS--
Leila Reyes, Manuel A Sanchez-Garcia, Tyler Morrison, et al.
Neurology
|
December 10, 2003
A haplotype at the PARK3 locus influences onset age for Parkinson's disease: the GenePD study
S Karamohamed, A L DeStefano, J B Wilk, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
June 21, 2005
Absence of previously reported variants in the SCNA (G88C and G209A), NR4A2 (T291D and T245G) and the DJ-1 (T497C) genes in familial Parkinson's disease from the GenePD study
Samer Karamohamed, L I Golbe, M H Mark, et al.
Iscience
|
February 28, 2022
Coagulation factor V is a T-cell inhibitor expressed by leukocytes in COVID-19
Jun Wang, Prasanti Kotagiri, Paul A Lyons, et al.
Page
of 55